Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 203,783 | 105,019 | 99,915 | 331,549 | 36,269 |
| Marketable Securities | 784,866 | 826,232 | 534,216 | 27,225 | 234,077 |
| Receivables | 134,476 | 53,822 | N/A | N/A | N/A |
| Inventories | 74,841 | 34,068 | 0 | N/A | N/A |
| TOTAL | $1,245,770 | $1,032,927 | $637,281 | $361,369 | $271,684 |
| Non-Current Assets | |||||
| PPE Net | 1,499 | 2,190 | 1,553 | 601 | 851 |
| Intangibles | 7,381 | 4,729 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,939 | 2,401 | 1,713 | 602 | 797 |
| TOTAL | $13,819 | $9,320 | $3,266 | $1,203 | $1,648 |
| Total Assets | $1,259,589 | $1,042,247 | $640,547 | $362,572 | $273,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,878 | 43,599 | 28,041 | 23,831 | 21,380 |
| Accrued Expenses | 260,392 | 124,695 | 89,980 | 91,461 | 55,048 |
| TOTAL | $310,288 | $169,277 | $118,548 | $115,894 | $76,838 |
| Non-Current Liabilities | |||||
| Long Term Debt | 339,881 | 117,569 | 115,480 | 49,289 | N/A |
| Other Non-Current Liabilities | 6,731 | 1,018 | 1,186 | 0 | 387 |
| TOTAL | $346,612 | $118,587 | $116,666 | $49,289 | $387 |
| Total Liabilities | $656,900 | $287,864 | $235,214 | $165,183 | $77,225 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,940 | 22,080 | 19,897 | 18,138 | 17,103 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -2,090,466 | -1,802,182 | -1,336,290 | -962,660 | -667,310 |
| Other shareholders' equity | 873 | 468 | 468 | -32 | -80 |
| TOTAL | $602,689 | $754,383 | $405,333 | $197,389 | $196,107 |
| Total Liabilities And Equity | $1,259,589 | $1,042,247 | $640,547 | $362,572 | $273,332 |